SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-263899
Filing Date
2020-10-05
Accepted
2020-10-05 16:20:00
Documents
7
Effectiveness Date
2020-10-05

Document Format Files

Seq Description Document Type Size
1 DEFA14A d907623ddefa14a.htm DEFA14A 34027
2 GRAPHIC g907623g05e15.jpg GRAPHIC 23408
3 GRAPHIC g907623g16q56.jpg GRAPHIC 13701
4 GRAPHIC g907623g62d05.jpg GRAPHIC 24728
5 GRAPHIC g907623g76c99.jpg GRAPHIC 32714
6 GRAPHIC g907623g84y44.jpg GRAPHIC 22433
7 GRAPHIC g907623g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-20-263899.txt   214843
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38268 | Film No.: 201223815
SIC: 2836 Biological Products, (No Diagnostic Substances)